APA (7th ed.) Citation

van Gemert, J., Luijk, B., Hellemons, M., Visser, K., Hansen, C., Meer, R. v. d., . . . Verschuuren, E. (2024). WS01.03 Effects of elexacaftor/tezacaftor/ivacaftor in lung transplant recipients with cystic fibrosis: The Dutch national KOALA study. Journal of cystic fibrosis, 23, S1-S2. https://doi.org/10.1016/S1569-1993(24)00109-7

Chicago Style (17th ed.) Citation

van Gemert, J.P, et al. "WS01.03 Effects of Elexacaftor/tezacaftor/ivacaftor in Lung Transplant Recipients with Cystic Fibrosis: The Dutch National KOALA Study." Journal of Cystic Fibrosis 23 (2024): S1-S2. https://doi.org/10.1016/S1569-1993(24)00109-7.

MLA (9th ed.) Citation

van Gemert, J.P, et al. "WS01.03 Effects of Elexacaftor/tezacaftor/ivacaftor in Lung Transplant Recipients with Cystic Fibrosis: The Dutch National KOALA Study." Journal of Cystic Fibrosis, vol. 23, 2024, pp. S1-S2, https://doi.org/10.1016/S1569-1993(24)00109-7.